Cro Apac Companies - Top Cros In Apac

Pharma Tech Outlook: Pharma Tech Magazine

Linkchem: Setting New Standards In The Cro Space

Top 10 CROs in APAC – 2022


Technology like AI/ML is spearheading big pharma companies by accelerating drug discovery. CROs are also stepping into the game by offering AI/ML solutions to help emerge and establish biopharmaceutical companies.

Another notable trend is the merging of CRO and CDMO activities to improve the inconsistencies in the early clinical phase trials. This merge is profoundly impacting pharmaceutical manufacturing, specifically vaccine manufacturing, both traditional adenoviral vectors and validating novel mRNA-based vaccines.

In the wake of these trends, the global CRO services market is projected to reach $163.48 billion by 2029, growing at a CAGR of 12.1 percent. The growth is especially driven by R&D budgets from pharmaceutical, biotechnology, medical device companies, governments, and medical research entities.

To put the spotlight on such key developments in the industry, Pharma Tech Outlook illustrates how pharma companies in the APAC region are leveraging leading-edge CROs to augment their services. This edition also features thought leadership articles from subject matter experts on ongoing trends, best practices, and recent innovations. Some of the exclusive insights are authored by Stewart Campbell and Li Chen, VPs & General Managers at West Pharmaceutical, Gil Carrasquinho, VP of Advisory Global Corporate Development Division at Santen, and Chris Dobbs, CEng MIET, Head of Technical Engineering at PCI Pharma Services. They shed light on enhancing biotech capabilities and solutions for various medical prospects in the healthcare industry.

In this edition of Pharma Tech Outlook magazine, we also bring to you the story of some of the top CROs in the APAC region that are facilitating unparalleled workflow optimizations for pharma companies and enhancing drug accessibility for patients. In the list, LinkChem particularly stands out for its broad experience and state-of-the-art infrastructure by making a difference by consolidating and combining a CRO + CDMO business model; HiRO stands out for its ability to deliver accelerated commercialization pathways to global biotech and pharma by providing innovative end to end clinical trial solutions; and WuXiAppTec, for giving a platform that transforms pharma outlook.

Through the following pages, we aim to highlight the innovative trends and latest developments in the CRO segment. We would like to know your thoughts.

    Top CROs in APAC

  • LinkChem’s discovery services cover the entire spectrum of early-stage research, from target identification to delivery of drug candidates.LinkChem has a significant track record of success, corporate stability, and expertise in providing integrated contact research organization (CRO) + contract development and manufacturing organization (CDMO) services.

  • Harvest Integrated Research Organization (HiRO) is a China-based globally oriented clinical research organization (CRO). With global operations and integrated capabilities, the company provides its clients with a full range of solutions and services, and strives to become a market-leading, global CRO that works conjunction with biotech and pharmaceutical companies to bring new products from the laboratory to market.

  • BradyKnows Medical is a medical device consulting firm that provides CRO services and facilitates the entire medical device lifecycle from, pre-market through post-market phases. With a focus on medical devices and in-vitro diagnostic products, the company serves as a major gateway to the Chinese market for global medical device manufacturers.

  • Equilab International is one of the first independent clinical research organizations (CROs) based out of Indonesia that is also the first WHO-accredited CRO in South East Asia. The firm provides services such as clinical trials, dermatology testing, contract analysis, central lab, pharmacokinetics services, and bioavailability/bioequivalence with faster timeline and high quality standard.

  • WuXiAppTec is a global company that provides comprehensive R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. The company’s operations span Asia, Europe, and North America.

  • Clinical Service Center

    Clinical Service Center

    Clinical Service Center is a full-service plus Contract Research Organization (CRO) providing comprehensive clinical trials services, including clinical operations, regulatory affairs, medical writing, statistical analysis, data management, pharmacovigilance, call center, quality assurance, training and consulting, etc.

  • PPD Inc

    PPD Inc

    PPD Inc is a global provider of clinical development and laboratory services, focused on operational excellence, they improve health by helping customers deliver life-changing medicines. They offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.

  • QPS Holdings

    QPS Holdings

    QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities.

  • SMC Laboratories,Inc.

    SMC Laboratories,Inc.

    SMC Laboratories,Inc. is a pre-clinical research organization (CRO) specialized in inflammation and fibrosis, including NASH, HCC, IPF, CKD and SSc with a mission to accelerate drug research and development through their focused fibrosis and inflammatory expertise.

  • Veristat


    Veristat is a scientific-minded global clinical research organization (CRO) that enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. The company focuses on novel drug development across complicated therapeutic areas, such as rare/ultra-rare disease, cell and gene therapies, oncology, and infectious disease trials.